3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Adenocarcinoma, Follicular
1
Interventions
Magnetic Resonance Spectroscopy
5
trametinib
3
Specimen Handling
3
dabrafenib
2
cabozantinib
2
X-Rays
2
Iodine-131
2
Interviews as Topic
2
tremelimumab
1
spartalizumab
1
pembrolizumab
1
omipalisib
1
lenvatinib
1
gallium Ga 68 dotatate
1
durvalumab
1
cobimetinib
1
Vemurafenib
1
Thyrotropin Alfa
1
Sodium Iodide
1
Phantoms, Imaging
1
Nivolumab
1
Ipilimumab
1
Iodine-124
1
High-Energy Shock Waves
1
Glycoprotein Hormones, alpha Subunit
1
Counseling
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma, Follicular
×
Sodium Iodide
×
1 year
×
Clear all
NCT01398085
2026-05-07
IoN
University College, London
Phase 2/3
Active not recruiting
504 enrolled